Table 3. FACS analysis of TBG-Dy uptake in orthotopic tumors.
LNCaP Cells/Tumor | Treatment | Injection | % Dy Positive |
---|---|---|---|
Cells | Untreated | N/A | 1.5 |
Tumor 1 | TBG-Dy | iv | 46.0 |
Tumor 2 | TBG-Dy | iv | 46.3 |
Tumor 3 | TBG-Dy | ip | 46.7 |
Mice received 200 nmol/kg TBG-Dy by intraperitoneal (ip) or tail vein (iv) injection 20 h prior to tumor excision and processing.